Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Clinical trial NCT04886284 · RECRUITING

Trial details

NCT number: NCT04886284
Sponsor: Todd C. Lee MD MPH FIDSA
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Staphylococcus Aureus Bacteremia Staphylococcus Aureus Septicemia Staphylococcal Sepsis Staphylococcus Aureus Endocarditis

Start date: 2024-05-20
Primary completion: 2027-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.